233 related articles for article (PubMed ID: 2211700)
1. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
Maimone MM; Tollefsen DM
J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700
[TBL] [Abstract][Full Text] [Related]
2. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
Halldórsdóttir AM; Zhang L; Tollefsen DM
Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
[TBL] [Abstract][Full Text] [Related]
3. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
Tollefsen DM
Adv Exp Med Biol; 1992; 313():167-76. PubMed ID: 1442260
[TBL] [Abstract][Full Text] [Related]
4. The disaccharides formed by deaminative cleavage of N-deacetylated glycosaminoglycans.
Shaklee PN; Conrad HE
Biochem J; 1986 Apr; 235(1):225-36. PubMed ID: 3741382
[TBL] [Abstract][Full Text] [Related]
5. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.
Mascellani G; Liverani L; Parma B; Bergonzini G; Bianchini P
Thromb Res; 1996 Oct; 84(1):21-32. PubMed ID: 8885144
[TBL] [Abstract][Full Text] [Related]
6. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.
Tollefsen DM; Peacock ME; Monafo WJ
J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134
[TBL] [Abstract][Full Text] [Related]
7. A sulfatase specific for glucuronic acid 2-sulfate residues in glycosaminoglycans.
Shaklee PN; Glaser JH; Conrad HE
J Biol Chem; 1985 Aug; 260(16):9146-9. PubMed ID: 4019466
[TBL] [Abstract][Full Text] [Related]
8. The interaction of glycosaminoglycans with heparin cofactor II.
Tollefsen DM
Ann N Y Acad Sci; 1994 Apr; 714():21-31. PubMed ID: 8017769
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis.
Volpi N; Maccari F
Glycobiology; 2009 Apr; 19(4):356-67. PubMed ID: 19056786
[TBL] [Abstract][Full Text] [Related]
10. Dermatan sulfate in tunicate phylogeny: order-specific sulfation pattern and the effect of [→4IdoA(2-sulfate)β-1→3GalNAc(4-sulfate)β-1→] motifs in dermatan sulfate on heparin cofactor II activity.
Kozlowski EO; Lima PC; Vicente CP; Lotufo T; Bao X; Sugahara K; Pavão MS
BMC Biochem; 2011 May; 12():29. PubMed ID: 21619699
[TBL] [Abstract][Full Text] [Related]
11. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
Blinder MA; Tollefsen DM
J Biol Chem; 1990 Jan; 265(1):286-91. PubMed ID: 2104620
[TBL] [Abstract][Full Text] [Related]
12. Structural determination of sulfated tetrasaccharides and hexasaccharides containing a rare disaccharide sequence, -3GalNAc(4,6-disulfate)beta1-4IdoAalpha1-, isolated from porcine intestinal dermatan sulfate.
Yamada S; Yamane Y; Sakamoto K; Tsuda H; Sugahara K
Eur J Biochem; 1998 Dec; 258(2):775-83. PubMed ID: 9874247
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
Van Deerlin VM; Tollefsen DM
J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
[TBL] [Abstract][Full Text] [Related]
14. Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque.
Shirk RA; Parthasarathy N; San Antonio JD; Church FC; Wagner WD
J Biol Chem; 2000 Jun; 275(24):18085-92. PubMed ID: 10749870
[TBL] [Abstract][Full Text] [Related]
15. Structural determination of novel tetra- and hexasaccharide sequences isolated from chondroitin sulfate H (oversulfated dermatan sulfate) of hagfish notochord.
Ueoka C; Nadanaka S; Seno N; Khoo KH; Sugahara K
Glycoconj J; 1999 Jun; 16(6):291-305. PubMed ID: 10579698
[TBL] [Abstract][Full Text] [Related]
16. Structural heterogeneity of dermatan sulfate chains: correlation with heparin cofactor II activating properties.
Denti A; Sini P; Tira ME; Balduini C
Thromb Res; 1995 Jul; 79(2):187-98. PubMed ID: 7676405
[TBL] [Abstract][Full Text] [Related]
17. A unique dermatan sulfate-like glycosaminoglycan from ascidian. Its structure and the effect of its unusual sulfation pattern on anticoagulant activity.
Pavão MS; Mourão PA; Mulloy B; Tollefsen DM
J Biol Chem; 1995 Dec; 270(52):31027-36. PubMed ID: 8537360
[TBL] [Abstract][Full Text] [Related]
18. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
[TBL] [Abstract][Full Text] [Related]
19. Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate.
Mascellani G; Liverani L; Bianchini P; Parma B; Torri G; Bisio A; Guerrini M; Casu B
Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):639-48. PubMed ID: 8280062
[TBL] [Abstract][Full Text] [Related]
20. The co-polymeric structure of pig skin dermatan sulphate. Distribution of L-iduronic acid sulphate residues in co-polymeric chains.
Cöster L; Malmström A; Sjöberg I; Fransson L
Biochem J; 1975 Feb; 145(2):379-89. PubMed ID: 1156366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
